1. Jaeger-Ruckstuhl, Carla A, Lo, Yun, Fulton, Elena, Furlan, Scott N, Riddell, Stanley R. . Signaling via a CD27-TRAF2-SHP-1 axis during naive T cell activation promotes memory-associated gene regulatory networks. In Immunity, 57, 287-302.e12. doi:10.1016/j.immuni.2024.01.011. https://pubmed.ncbi.nlm.nih.gov/38354704/
2. Li, Jie, Zhang, Jingyu, Zhang, Yusuo, Jia, Jia, Cheng, Jian. 2019. TRAF2 protects against cerebral ischemia-induced brain injury by suppressing necroptosis. In Cell death & disease, 10, 328. doi:10.1038/s41419-019-1558-5. https://pubmed.ncbi.nlm.nih.gov/30988281/
3. Xu, Yawei, Li, Lei, Yang, Wuping, Zhou, Jingcheng, Gong, Kan. 2023. TRAF2 promotes M2-polarized tumor-associated macrophage infiltration, angiogenesis and cancer progression by inhibiting autophagy in clear cell renal cell carcinoma. In Journal of experimental & clinical cancer research : CR, 42, 159. doi:10.1186/s13046-023-02742-w. https://pubmed.ncbi.nlm.nih.gov/37415241/
4. Xu, Shanshan, Kong, Jiangping, Huang, Li, Xu, Shengqian, Pan, Faming. 2021. Single nucleotide polymorphisms of TRAF2 and TRAF5 gene in ankylosing spondylitis: a case-control study. In Clinical and experimental medicine, 21, 645-653. doi:10.1007/s10238-021-00719-7. https://pubmed.ncbi.nlm.nih.gov/33997937/
5. Yan, Rong, Zhu, Hongyan, Huang, Piao, Hao, Piliang, Qu, Yi. . Liquidambaric acid inhibits Wnt/β-catenin signaling and colon cancer via targeting TNF receptor-associated factor 2. In Cell reports, 38, 110319. doi:10.1016/j.celrep.2022.110319. https://pubmed.ncbi.nlm.nih.gov/35108540/
6. Rathore, Ujjwal, Haas, Paige, Easwar Kumar, Vigneshwari, Kaake, Robyn M, Krogan, Nevan J. 2024. CRISPR-Cas9 screen of E3 ubiquitin ligases identifies TRAF2 and UHRF1 as regulators of HIV latency in primary human T cells. In mBio, 15, e0222223. doi:10.1128/mbio.02222-23. https://pubmed.ncbi.nlm.nih.gov/38411080/